Distribution of theblaOXA-23-containing transposons Tn2006and Tn2008in Australian carbapenem-resistantAcinetobacter baumanniiisolates: Figure 1.

Snapshot on carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii in Bucharest hospitals reveals unusual clones and novel genetic surroundings for blaOXA-23

(2015) I. Gheorghe et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid

(2014) S. J. Nigro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tn6167, an antibiotic resistance island in an Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 isolate

(2012) S. J. Nigro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tn2008 is a major vehicle carrying blaOXA-23 in Acinetobacter baumannii from China

(2011) Xiaohui Wang et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Adherence and motility characteristics of clinical Acinetobacter baumannii isolates

(2011) Bart A. Eijkelkamp et al.   FEMS MICROBIOLOGY LETTERS

Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals

(2011) S. J. Nigro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Functional Analysis of Insertion Sequence ISAba1, Responsible for Genomic Plasticity of Acinetobacter baumannii

(2009) P. D. Mugnier et al.   JOURNAL OF BACTERIOLOGY

Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.

(2008) L. Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania

(2008) J. M. Adams-Haduch et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY